系统性红斑狼疮患者HDL胆固醇外流能力受损与亚临床颈动脉粥样硬化相关
横断面研究纳入195例SLE患者和223例对照,评估胆固醇外流能力(CEC)与亚临床颈动脉粥样硬化的关系。SLE患者CEC显著降低,且独立于传统心血管危险因素和他汀使用;多变量回归显示CEC与颈动脉斑块存在独立负相关。
要点
- SLE患者CEC较对照组显著降低,且独立于传统心血管危险因素。
- CEC与SLE疾病活动度、严重程度或损伤无关。
- CEC与颈动脉斑块独立负相关,提示其或反映亚临床动脉粥样硬化。
核心结论
- SLE患者CEC受损,独立于疾病相关炎症性脂质谱改变。
- CEC与SLE患者颈动脉斑块存在独立负相关。
研究设计与样本
- 横断面研究纳入418人,其中195例SLE患者和223例对照。
- 采用体外实验评估CEC和脂蛋白血清浓度,SLE患者评估颈动脉内膜中层厚度和斑块。
主要发现
- SLE患者CEC为8.1(4.2)%,对照组为16.9(10.4)%,P=0.004。
- 传统心血管危险因素及SLE活动、严重程度或损伤均与CEC无关。
- 多变量回归分析中,CEC与SLE患者颈动脉斑块存在独立负相关,OR 0.87(95%CI:0.78,0.97),P=0.014。
临床怎么用
- 在SLE患者中,CEC降低可能提示亚临床颈动脉粥样硬化风险,可结合颈动脉超声评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Lipid profiles appear to be altered in SLE patients due to disease activity and inflammation. Cholesterol efflux capacity (CEC) is the ability of high-density lipoprotein cholesterol to accept cholesterol from macrophages. CEC has been linked to cardiovascular events in the general population and is impaired in SLE patients. The aim of this study was to establish whether CEC is related to subclinical carotid atherosclerosis in SLE patients. METHODS: The present report is of a cross-sectional study that encompassed 418 individuals: 195 SLE patients and 223 controls. CEC, using an in vitro assay, and lipoprotein serum concentrations were assessed in patients and controls. Carotid intima-media thickness and carotid plaques were evaluated in SLE patients. A multivariable analysis was performed to study the relationship of CEC to SLE-related data, lipid profile and subclinical carotid atherosclerosis. RESULTS: CEC was downregulated in SLE patients [8.1 (4.2) % vs 16.9 (10.4) %, P = 0.004). This occurred independently of traditional cardiovascular risk factors, statin use or other variations in the lipid profile related to the disease. Traditional cardiovascular risk factors, both in patients and controls, and SLE-related data such as activity, severity or damage were not associated with CEC. After multivariable regression analysis including lipid profile-related molecules, CEC was inversely and independently associated with the presence of carotid plaques in SLE patients [odds ratio 0.87 (95% CI: 0.78, 0.97), P = 0.014]. CONCLUSION: CEC is impaired in SLE patients independently of other inflammation-related lipid profile modifications that occur during the disease. CEC is associated with carotid plaques in SLE patients.
引用
- Sánchez-Pérez H, Quevedo-Abeledo JC, de Armas-Rillo L, et al. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis. Rheumatology (Oxford). 2020. PMID: 32065639. doi:10.1093/rheumatology/keaa038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。